Pacer Advisors Inc. increased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 757.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 485,046 shares of the technology company’s stock after buying an additional 428,478 shares during the quarter. Pacer Advisors Inc. owned about 0.30% of Veeva Systems worth $85,203,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC lifted its stake in shares of Veeva Systems by 225.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock valued at $899,000 after purchasing an additional 2,164 shares during the last quarter. Bank of Nova Scotia grew its holdings in shares of Veeva Systems by 44.5% during the 2nd quarter. Bank of Nova Scotia now owns 5,866 shares of the technology company’s stock worth $1,689,000 after purchasing an additional 1,806 shares during the period. NewEdge Advisors LLC increased its position in shares of Veeva Systems by 34.6% during the 2nd quarter. NewEdge Advisors LLC now owns 8,832 shares of the technology company’s stock worth $2,543,000 after purchasing an additional 2,272 shares during the last quarter. Treasurer of the State of North Carolina increased its position in shares of Veeva Systems by 2.2% during the 2nd quarter. Treasurer of the State of North Carolina now owns 68,950 shares of the technology company’s stock worth $19,856,000 after purchasing an additional 1,452 shares during the last quarter. Finally, Diversify Wealth Management LLC raised its holdings in Veeva Systems by 5.3% in the 2nd quarter. Diversify Wealth Management LLC now owns 11,399 shares of the technology company’s stock valued at $3,140,000 after buying an additional 575 shares during the period. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Veeva Systems Price Performance
Shares of Veeva Systems stock opened at $204.09 on Monday. The stock has a market capitalization of $33.15 billion, a price-to-earnings ratio of 36.38, a price-to-earnings-growth ratio of 0.88 and a beta of 0.92. The business has a 50-day moving average of $178.56 and a 200 day moving average of $180.04. Veeva Systems Inc. has a 12 month low of $148.05 and a 12 month high of $310.50.
Analyst Ratings Changes
VEEV has been the topic of a number of recent analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $275.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Raymond James Financial reissued an “outperform” rating and issued a $225.00 price target on shares of Veeva Systems in a research note on Thursday, June 4th. UBS Group decreased their price objective on shares of Veeva Systems from $220.00 to $190.00 and set a “neutral” rating on the stock in a report on Thursday, June 4th. Piper Sandler lowered their price objective on shares of Veeva Systems from $285.00 to $235.00 and set an “overweight” rating for the company in a research report on Thursday, June 4th. Finally, Guggenheim started coverage on shares of Veeva Systems in a report on Thursday, July 23rd. They issued a “buy” rating and a $232.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Veeva Systems has a consensus rating of “Moderate Buy” and an average price target of $247.08.
Check Out Our Latest Research Report on Veeva Systems
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
